Syngenta Crop Protection and Agrauxine by Lesaffre Announce Private Label and Supply Agreement
Syngenta Crop Protection has signed an agreement with Agrauxine by Lesaffre to private label and exclusively distribute Syngenta’s products STROVEQ and SPREXIMA. STROVEQ is a systemic resistance inducer and SPREXIMA, is a biofungicide. These products will be sold and distributed in the ornamental market in the U.S. This agreement further strengthens the collaboration between Agrauxine and Syngenta.
Both STROVEQ and SPREXIMA utilize Agrauxine’s unique strains of Saccharomyces cerevisiae yeast. STROVEQ is a systemic resistance Inducer (SRI) that acts preventively to prepare plants to defend against fungal attacks. SPREXIMA prevents disease infections by protecting fruits, flowers and wounds.
“We are extremely excited to partner with Syngenta,” states Ariel Gohlke, North American Regional Manager for Agrauxine. “This agreement is another opportunity to expand the reach of our technology. Syngenta will be an excellent partner for us to reach more markets with our unique products.”
Syngenta has been investing significantly in strengthening its portfolio of biological solutions for both plant and seed health. It has continued to expand its portfolio of cutting-edge biological solutions through various commercial and research collaborations.
“Syngenta consistently looks to bring new innovations to serve the Ornamental market,” says Carson Cashwell, Ornamental Market Manager for Syngenta. “Our partnership with Agrauxine will provide Ornamental growers with new solutions to help protect their crops while leveraging Syngenta’s existing portfolio and team.”
The agreement states that Syngenta shall have the right to sell the products at its discretion and is authorized to distribute through its own distribution channels in the US. The initial term of the agreement is 5 years.